πŸ‡ΊπŸ‡Έ FDA
Patent

US 11752190

Modulators of complement activity

granted A61KA61K38/12A61K9/0019

Quick answer

US patent 11752190 (Modulators of complement activity) held by RA PHARMACEUTICALS, INC. expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
RA PHARMACEUTICALS, INC.
Grant date
Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/12, A61K9/0019, A61P, A61P37/02